Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Medical Device Metabolic Experience
Medpace Medical Device

Want to learn more about the Medpace difference for medical device studies? Simply fill out this form and we will contact you.


Medpace Medical Device
3787 95th Avenue
Suite 100
Blaine, MN 55014 USA
Tel: +1.612.234.8500
Fax: +1.612.234.8501

Medpace Medical Device B.V.
Maastrichterlaan 127-129
NL – 6291 EN Vaals
Tel: +31.43.306.3320
Fax: +31.43.306.3338

MMD E-mail:


VIEW NOW View now
  • Fact Sheet: MMD Overview
  • Fact Sheet: Cardiovascular
  • Fact Sheet: Ophthalmic
  • Fact Sheet: Orthopedic

  • Metabolic Device Experience

    Medpace Medical Device’s experience with metabolic products spans hundreds of global sites and thousands of patients for diabetes, obesity and weight loss indications.
    • Glucose monitoring devices
    • Insulin delivery devices
    • Gastric stimulation
    • Gastric balloons

    Therapeutic and Regulatory Experts

    Medpace’s therapeutic and regulatory experts helped pioneer many preventative metabolic compounds and have extensive experience in the design and execution of medical device trials. Our dedicated teams - led by therapeutic and regulatory specialists - ensure your project receives the collective knowledge, talent and relationships of our seasoned experts.

    Drug-Device Combinaton products

    Since 1992, Medpace has conducted thousands of endocrine/metabolic trials around the globe including significant involvement in 20 NDA submissions. Our experience with large-scale multinational trial programs, including in emerging markets, and our broad compound experience for Type 1 and Type 2 diabetes, major obesity programs, hypercholesterolemia, mixed dyslipidemia, and/or with very high triglycerides, provides a strong backdrop for sponsors with drug-device combination products. With both a dedicated Medical Device division, and this industry-leading experience in metabolic drug development, Medpace brings together its medical and regulatory experts into a collaborative team that understands the nuances from both the drug and device perspectives.